Virginia Administrative Code › Title 11 - GAMING › Agency 10 - VIRGINIA RACING COMMISSION › Chapter 180 - MEDICATION › Section 11VAC10-180-60 - Medications and prohibited substances

Current through Register Vol. 40, No. 24, July 15, 2024
A. Medications and prohibited substances are
				divided into five classes. The classes are:
1. Class 1. Substances found in this class
				have no generally accepted medical use in the racehorse and have a very high
				pharmacological potential for altering the performance of a racehorse. These
				substances should never be found in the horse's system through postrace testing
				or in the possession of any holder of a permit within the enclosure of a horse
				racing facility licensed by the commission. Such substances are potent
				stimulants of the nervous system including opiates, opium derivatives,
				synthetic opioids, psychoactive drugs, amphetamines and U.S. Drug Enforcement
				Agency (DEA) Schedules I and II controlled substances.
2. Class 2. Substances in this class have a
				high potential to affect the outcome of a race. Most are not generally accepted
				as therapeutic agents in the racehorse. Many are products intended to alter
				consciousness or the psychic state of humans and have no approved or indicated
				use in the horse. Some, such as injectable local anesthetics, have legitimate
				uses in equine medicine but should not be found in a racehorse through postrace
				testing. The following groups of substances are in this class:
a. Opiate partial agonists or
				agonist-antagonists;
b. Nonopiate
				psychotropic drugs, which may have stimulant, depressant, analgesic or
				neuroleptic effects;
c.
				Miscellaneous substances that might have a stimulant effect on the central
				nervous system (CNS);
d. Drugs with
				prominent CNS depressant action;
e.
				Antidepressant and antipsychotic drugs, with or without prominent CNS
				stimulatory or depressant effects;
f. Muscle-blocking substances that have a
				direct neuromuscular blocking action;
g. Local anesthetics that have a reasonable
				potential for use as nerve-blocking agents (except procaine);
h. Other biological substances and snake
				venoms or chemicals that may be used as nerve-blocking agents; and
i. Erythropoietin (Epogen), darbepoietin,
				oxyglobin, hemopure, or other blood-doping agents.
3. Class 3. Substances found in this class
				may or may not have an accepted therapeutic use in the horse but have a
				potential to enhance performance, and their presence in the horse's system is
				prohibited on race day. The following groups of substances are in this class:
a. Substances affecting the autonomic nervous
				system that do not have prominent CNS effects, but that do have prominent
				cardiovascular and respiratory system effects (bronchodilators are included in
				this category);
b. Local
				anesthetics that have nerve-blocking potential but also a high potential for
				producing urine residue levels from a method of use not related to the
				anesthetic effect of the substance (procaine);
c. Miscellaneous substances with mild
				sedative action, such as the sleep-inducing antihistamines;
d. Primary vasodilating/hypotensive
				agents;
e. Potent diuretics
				affecting renal function and body fluid composition; and
f. Anabolic and/or androgenic steroids and/or
				growth hormones other than boldenone, stanozolol, nandrolone, and testosterone,
				which are classified elsewhere in this section.
4. Class 4. Substances in this class are
				primarily therapeutic medications routinely used in racehorses. These may
				influence performance, but generally have a more limited ability to do so. The
				following groups of drugs are in this class:
a. Nonopiate substances that have a mild
				central analgesic effect;
b.
				Substances affecting the autonomic nervous system that do not have prominent
				CNS, cardiovascular or respiratory effects:
(1) Substances used solely as topical
				vasoconstrictors or decongestants;
(2) Substances used as gastrointestinal
				antispasmodics;
(3) Substances used
				to void the urinary bladder; and
(4) Substances with a major effect on CNS
				vasculature or smooth muscle of visceral organs.
(5) Antihistamines that do not have a
				significant CNS depressant effect (this does not include H1 blocking agents,
				which are listed in Class 3).
c. Mineral corticoid substances;
d. Skeletal muscle relaxants;
e. Anti-inflammatory substances that may
				reduce pains as a consequence of their anti-inflammatory actions, which
				include:
(1) Nonsteroidal anti-inflammatory
				drugs (NSAIDs);
(2) Corticosteroids
				(glucocorticoids); and
(3)
				Miscellaneous anti-inflammatory agents.
f. Boldenone, stanozolol, nandrolone, and
				testosterone, individually but not in combination, at levels stipulated in
				11VAC10-180-75.
g. Less potent diuretics;
h. Cardiac glycosides and antiarrhythmics
				including:
(1) Cardiac glycosides;
(2) Anti-arrhythmic agents (exclusive of
				lidocaine, bretylium and propranolol); and
(3) Miscellaneous cardiotonic
				drugs.
i. Topical
				anesthetics agents not available in injectable formulations;
j. Antidiarrheal agents; and
k. Miscellaneous substances including:
(1) Expectorants with little or no other
				pharmacologic action;
(2)
				Stomachics; and
(3) Mucolytic
				agents.
5.
				Class 5. Drugs in this class are therapeutic medications for which
				concentration limits have been established as well as certain miscellaneous
				agents. Included specifically are agents that have very localized action only,
				such as anti-ulcer drugs and certain anti-allergenic drugs. The anticoagulant
				drugs are also included.